“Everything is practically open now, and the atmosphere is so different, so much lighter and joyful. We feel safe while the other cities around us are in a very difficult situation,” says Ricardo Luiz, owner of a well-known restaurant in Serrana.
Four months after the kickoff of the experiment known as Project S, this quiet city surrounded by sugar plantations has acquired an atmosphere of pre-pandemic days, Luiz says.
His business is getting back on its feet after one year of hardship and it’s currently bringing in 70% of the revenue it made before the pandemic.
“People feel safe to leave the house,” he says, adding that he no longer feels afraid for his family or acquaintances traversing the city’s hot and dry streets. “We know everyone here, and nowadays it’s rare to hear about cases and deaths,” he says.
Nationwide, Brazil has the second-highest number of deaths from Covid-19 in the world, after the US, and it is heading to its third wave with daily cases and deaths on the rise. Only 10% of Brazil´s population is fully vaccinated.
But people living in Serrana say they’re experiencing a very different reality, thanks to Project S.
the biomedical center Butantan Institute in partnership with the Sao Paulo University of Medicine in Ribeirao Preto. This spring, researchers gave the full two doses of the vaccine Coronavac to 27,160 adults — about 95% of the city’s adult population. The Coronavac, designed by Chinese pharmaceutical Sinovac and produced in part in Brazil in partnership with Butantan, has shown a global efficacy of
50.8% in Phase III tests.
Researchers’ full findings from Project S have not yet been peer-reviewed or published. However, according to preliminary results released on June 1, the study showed an 80% reduction in the number of symptomatic cases. Covid-related hospitalizations have fallen by 86% and mortality by 95% — figures hailed by Sao Paulo Governor Joao Doria as a good omen for the rest of the country.
According to the study, the immunization generated a kind of “immune belt” in Serrana, drastically reducing the transmission of coronavirus in the municipality even as the virus raged throughout the country.
“The most important result was to understand that we can control the pandemic even without vaccinating the entire population. When coverage reached 70%, 75% (of Serrana’s population), the drop in incidence was noticed even in the group that had not yet completed the vaccination schedule,” said Ricardo Palacios, medical director of clinical research at Instituto Butantan in an interview with CNN International a day after the news conference.
But until the Butantan Institute releases its complete study data and it is peer-reviewed, not everyone is leaping to applaud the results — nor to relax hygiene precautions.
Jose Angelo Marques owns a beauty salon in Serrana, and was fully vaccinated back in April. His business is operating with protocols established by Sao Paulo state government such as limited attending capacity and distancing between customers, and Marques says he won’t lift them until he sees the numbers behind the percentages.
“I wish I could see the numbers. That would make me feel safer,” he says.
He, his wife and his parents all were infected with Covid-19 last year. Most had mild symptoms or were asymptomatic, but Marques’ 81-year-old father died from Covid-19 less than a month later.
Being vaccinated has helped the family to deal with their grief, however, Marque admits. “We have now loosened up a bit. We are now close to each other, hugging each other and that has been helping us a lot to cope with the absence of my father.”
Why Serrana
About 330 kilometers away from the state capital Sao Paulo, Serrana is considered a bedroom community, with much of its population commuting to work in larger neighboring cities like Ribeirao Preto. That flow of people caused a high prevalence of Covid-19 infections at the beginning of 2021, according to Marcos Borges, main researcher at Project S.
“More than 10,000 people here go to work in other cities. This leads to the vast spread of these infectious and contagious diseases,” said Borges. “One out of 20 people in Serrana was infected and transmitting the disease and that caught our attention.”
“We were suffering so much with Covid-19 here at the beginning of the year. It hit us very hard. Our small health system collapsed. It was like a very dark cloud was above the town,” says Serrana Mayor Leonardo Capitelli.
Brazil has struggled to acquire sufficient vaccines for its population of 211 million. Knowing that herd immunity could be a long time coming for the country, Butantan Institute Director Dimas Covas and Borges sought to vaccinate a high percentage of the population in Serrana in a short period of time, to see if herd immunity could be achieved locally.
“So we wanted to test whether vaccination can prevent the transmission of the virus, reduce serious cases and hospitalization,” Borges says. Serrana’s then-high prevalence of Covid-19, small population and proximity to the medical university in Ribeirao Preto and the state hospital, made it an ideal candidate.
The method used in the clinical trial is called a stepped-wedge trial, in which the city was divided into 25 sub-areas, forming four large population groups that received the vaccine in successive weeks between February and April.
Ricardo Palacios says that scheduling vaccinations sequentially allowed the research team to evaluate and compare the areas.
“By the time the third group received its second dose, about 75% of the eligible population, we noticed that the outbreak was effectively under control across the city,” he said, adding that it signaled that widespread vaccination could indirectly protect even non-immunized populations, such as children and adolescents.
“The reduction in cases in people who did not receive the vaccine indicates a drop in the circulation of the virus. This reinforces vaccination as a public health measure, and not just an individual one,” he said.
Mayor Capitelli says Serrana’s two primary care hospitals are much less crowded today.
“Forty, fifty days ago we had about 160 to 180 people coming every day to our hospitals showing symptoms of respiratory syndrome, and about 69% tested positive for Covid-19. Now, hospital attendance has gone down to 30, 35 people a day and only 20 to 25% test positive for Covid-19,” he said.
“We had one Serrana before Project S, and another after. Our economy is growing, many new companies are interested in investing here, people are back to their lives and we are getting better by the day,” the mayor added.
But the masks stay on
Yet life isn’t entirely back to normal.
Because the virus remains out of control in the region, Serrana residents are still required to wear masks and social distance, a basic sanitary order enforced across the state.
Businesses in Serrana also maintain state government restrictions limiting capacity, in contrast to complete closures imposed in some nearby cities.
“This still has to be followed because the region is in chaos, with cities and health systems collapsed,” says Mayor Capitelli.
The study’s full results are expected to be published by the beginning of July. But Project S. will continue until February next year, with researchers continuously monitoring Serrana’s residents. As new viral variants keep appearing, researchers hope that the Coronavac retains its effectiveness — and that Serrana will continue to enjoy its apparent victory.
“The important conclusions of the study may support the immunization strategies in Brazil and in the world, and offer hope for the control of the pandemic with vaccines such as Coronavac,” said Dimas Covas, head of Butantan Institute.
For now, Ricardo Luiz, the restaurant owner, says he can already feel the psychological benefit of participating in Project S.
“My hope is restored. Even my self-esteem is back,” he says.
“Four months ago it was difficult to see the end of all of this. We are a small city and we know everyone. We felt the pain of others as if it was ours. It was hard. But now we can see light at the end of the tunnel, we can see it is possible to go back to normal, and we can feel happy again.”